NeuroPace: Clinical Trials

3 trials sponsored by NeuroPace, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Active not recruiting 1

Follow NeuroPace: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RNS System LGS Feasibility Study
RNS System - Epilepsy, Lennox Gastaut Syndrome
Phase 2Active not recruitingNeuroPace242022-10-042026-09-15
RNS® System Feasibility Study
RNS® System implantation, RNS® System responsive stimulation - Epilepsy
Phase 2CompletedNeuroPace702004-01-012014-01-29
Study of an External Responsive Neurostimulator System on Epileptiform Activity
external Responsive Neurostimulator (eRNS) System - Epilepsy
Phase 2CompletedNeuroPace1502002-03-012010-08-26

Conditions studied

Epilepsy (3)  ·  Seizures (2)  ·  Lennox Gastaut Syndrome (1)

Interventions

Drug Delivery Systems (1)

Countries

United States (3)

Top investigators

Anthony Murro, MD (1)  ·  Bruce Fisch, MD (1)  ·  Donna Bergen, MD (1)  ·  Douglas Labar, MD (1)  ·  Greg Bergey, MD (1)  ·  Gregory Barkley, MD (1)  ·  Martha Morrell, MD (1)  ·  Michael Smith, MD (1)  ·  Richard Marsh, MD (1)  ·  Richard Zimmerman, MD (1)  ·  Robert Duckrow, MD (1)  ·  Robert Goodman, MD (1)  ·  Robert Wharen, MD (1)  ·  Ryder Gwinn, MD (1)

Results publications

PMID 42663529

NIH funding

UH3NS109557 (1)